XML 63 R45.htm IDEA: XBRL DOCUMENT
v3.20.4

Long-Term Investments (Details 1) | 12 Months Ended
--- | ---
Dec. 31, 2020
BioFirst Corporation [Member] |
Relationship with the Company and its subsidiaries, description | Entity controlled by controlling beneficiary shareholder of Yuangene
Braingenesis Biotechnology Co., Ltd. [Member] |
Relationship with the Company and its subsidiaries, description | No specific business relationship
Genepharm Biotech Corporation [Member] |
Relationship with the Company and its subsidiaries, description | No specific business relationship
BioHopeKing Corporation [Member] |
Relationship with the Company and its subsidiaries, description | Collaborating with the Company to develop and commercialize drugs
Rgene Corporation [Member] |
Relationship with the Company and its subsidiaries, description | Collaborating with the Company to develop and commercialize drugs

X
- Definition It represents related party descriptions. + References No definition available. + Details
Name: | abvcd_RelatedPartyTransactionDescriptionOfTransactions
Namespace Prefix: | abvcd_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | us-gaap_RelatedPartyTransactionAxis=abvcd_BioFirstCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvcd_BraingenesisBiotechnologyCoLtdMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvcd_GenepharmBiotechCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvcd_BioHopeKingCorporationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |

X
- Details
Name: | us-gaap_RelatedPartyTransactionsByRelatedPartyAxis=abvcd_RgeneMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |